Skip to main content

Animations

MJFF Publications

8091 - 8100 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2018
  • 2024
  • 2025
  • 2021
  • 2019
  • 2021
  • 2018
  • 2025
  • Summary Details
    OPEN
    Title: Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jnc.16298
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/ejn.15917
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women
    Journal Name: Multiple Sclerosis and Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.msard.2018.11.015
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Quantifying arm swing in Parkinson’s disease: a method accounting for arm activities during free-living gait
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-025-01578-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    Journal Name: Physiology News
    Publisher: The Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.36866/123.32
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: End of life planning in parkinsonian diseases
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.026
    Citation Count: 9
  • Summary Details
    OPEN
    Title: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.003
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.